Filing Details
- Accession Number:
- 0001127602-10-030090
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-09 16:12:34
- Reporting Period:
- 2010-12-07
- Filing Date:
- 2010-12-09
- Accepted Time:
- 2010-12-09 16:12:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 64803 | Cvs Caremark Corp | CVS | Retail-Drug Stores And Proprietary Stores (5912) | 050494040 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1194416 | M Thomas Ryan | One Cvs Drive Woonsocket RI 02895 | Chairman Of The Board And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-12-07 | 1,012,124 | $14.96 | 1,776,807 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-12-07 | 1,012,124 | $33.06 | 764,683 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-12-07 | 400,000 | $22.45 | 1,164,683 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-12-07 | 400,000 | $33.06 | 764,683 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2010-12-07 | 1,012,124 | $0.00 | 1,012,124 | $14.96 |
| Common Stock | Stock Option | Disposition | 2010-12-07 | 400,000 | $0.00 | 400,000 | $22.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2003-01-02 | 2012-01-02 | No | 4 | M | Direct |
| 0 | 2006-01-05 | 2012-01-05 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 801,291 | Indirect | By Trust As Beneficiary |
| Common Stock (Restricted) | 614,722 | Direct | |
| Esop Common Stock | 8,316 | Indirect | By ESOP |
| Stock Unit | 1,083,265 | Direct | |
| Common Stock | 37,000 | Indirect | By Foundation |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Phantom Stock Credits | $1.00 | 17,156 | 17,156 | Direct | ||
| Common Stock | Stock Option | $25.00 | 2001-03-10 | 2009-03-10 | 298,300 | 298,300 | Direct |
| Common Stock | Stock Option | $12.56 | 2005-01-09 | 2013-01-09 | 900,000 | 900,000 | Direct |
| Common Stock | Stock Option | $30.04 | 2007-04-03 | 2013-04-03 | 491,761 | 491,761 | Direct |
| Common Stock | Stock Option | $34.42 | 2008-04-02 | 2014-04-02 | 403,226 | 403,226 | Direct |
| Common Stock | Stock Option | $41.17 | 2009-04-01 | 2015-04-01 | 634,233 | 634,233 | Direct |
| Common Stock | Stock Option | $28.10 | 2010-04-01 | 2016-04-01 | 660,205 | 660,205 | Direct |
| Common Stock | Stock Option | $36.23 | 2011-04-01 | 2017-04-01 | 446,215 | 446,215 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 17,156 | 17,156 | Direct | |
| 2009-03-10 | 298,300 | 298,300 | Direct |
| 2013-01-09 | 900,000 | 900,000 | Direct |
| 2013-04-03 | 491,761 | 491,761 | Direct |
| 2014-04-02 | 403,226 | 403,226 | Direct |
| 2015-04-01 | 634,233 | 634,233 | Direct |
| 2016-04-01 | 660,205 | 660,205 | Direct |
| 2017-04-01 | 446,215 | 446,215 | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $33.00 and $33.08 per share.
- Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $33.00 and $33.08 per share.
- Each share credit is equivalent to one share; 1-for-1 conversion.
- Reflects 2002 and 2003 year end company match share credits of 33 and 581, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
- Reflects employee contribution share credits and year end company match share credits, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
- Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
- Option becomes exercisable in three equal annual installments, commencing 4/3/2007.
- Option becomes exercisable in three equal annual installments, commencing 4/2/2008.
- Option becomes exercisable in three equal annual installments, commencing 4/1/2009.
- Option becomes exercisable in three equal annual installments, commencing 4/1/2010.
- Option becomes exercisable in three equal annual installments, commencing 4/1/2011.
Billionaire Hedge Funds
